Your Trusted Brand for Over 35 Years

Vertigo References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Oghalai JS, Manolidis S, et al. Unrecognized benign paroxysmal positional vertigo in elderly patients. Otolaryngol Head Neck Surg. 2000 May;122(5):630-4.
  2. Crespi V. Dizziness and vertigo: an epidemiological survey and patient management in the emergency room. Neurol Sci. 2004 Mar;25 (suppl 1):S24-S25.
  3. Salvenelli F, Firrisi L, et al. Benign paroxysmal positional vertigo: diagnosis and treatment. Clin Ter. 2004 Sep;155(9):395-400.
  4. Gordon CR, Joffe V, et al. Traumatic benign paroxysmal positional vertigo: diagnosis and treatment. Harefuah. 2002 Nov;141(11):944-7,1011-2.
  5. Goplen F, Nordahl SH. Benign paroxysmal positional vertigo. Tidsskr Nor Laegeforen. 2002 Jun 10;122(15):1463-6.
  6. Bertholon P, Faye MB, et al. Benign paroxysmal positional vertigo of the horizontal canal: clinical features in 25 patients. Ann Otolaryngol Chir Cervicofac. 2002 Apr;119(2):73-80.
  7. Parnes LS, Agrawal SK , et al. Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ. 2003 Sep 30;169(7):681-93.
  8. da Costa SS, de Sousa LC, et al. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am. 2002 Jun;35(3):455-95.
  9. Megerian CA. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Meniere's disease. Laryngoscope. 2005 Sep;115(9):1525-35.
  10. Semaan MT, Alagramam KN, et al. The basic science of Meniere's disease and endolymphatic hydrops. Curr Opin Otolaryngol Head Neck Surg. 2005 Oct;13(5):301-7.
  11. Takumida M, Anniko M, et al. Pharmacological models for inner ear therapy with emphasis on nitric oxide. Acta Otolaryngol. 2001 Jan;121(1):16-20.
  12. Raponi G, Alpini D, et al. The role of free radicals and plasmatic antioxidant in Meniere's syndrome. Int Tinnitus J. 2003;9(2):104-8.
  13. de Sousa LC, Piza MR, et al. Diagnosis of Meniere's disease: routine and extended tests. Otolaryngol Clin North Am. 2002 Jun;35(3):547-64.
  14. El-Kashlan HK, Telian SA. Diagnosis and initiating treatment for peripheral system disorders: imbalance and dizziness with normal hearing. Otolaryngol Clin North Am. 2000 Jun;33(3):563-78.
  15. Eckhardt-Henn A, Hoffmann SO, et al. “Phobic postural vertigo”: a further differentiation of psychogenic vertigo conditions seems necessary. Nervenarzt. 1997 Oct;68(10):806-12.
  16. Dieterich M. Detecting phobic vertigo! MMW Fortschr Med. 2000 Jan 20;142(3):26-9.
  17. Bir LS, Ardic FN, et al. Migraine patients with or without vertigo: comparison of clinical and electronystagmographic findings. J Otolaryngol. 2003 Aug;32(4):234-8.
  18. Ernst A, Basta D, et al. Management of posttraumatic vertigo. Otolaryngol Head Neck Surg. 2005 Apr;132(4):554-8.
  19. Baloh RW. Episodic vertigo: central nervous system causes. Curr Opin Neurol. 2002 Feb;15(1):17-21.
  20. Epley JM. Canalith repositioning maneuver. Otolaryngol Head Neck Surg. 1994 Nov;111(5):688-90.
  21. Takumida M, Anniko M, et al. Radical scavengers for Meniere's disease after failure of conventional therapy: a pilot study. Acta Otolaryngol. 2003 Aug;123(6):697-703.
  22. Shulman A. Neuroprotective drug therapy: a medical and pharmacological treatment for tinnitus control. Int Tinnitus J. 1997;3(2):77-93.
  23. Claussen CF, Claussen E. Antivertiginous action of vitamin B6 on experimental minocycline-induced vertigo in man. Arzneimittelforschung. 1988 Mar;38(3):396-9.
  24. Orendorz-Fraczkowska K, Pospiech L, et al. Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761). Otolaryngol Pol. 2002;56(1):83-8.
  25. Cesarani A, Meloni F, et al. Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther. 1998 Sep-Oct;15(5):291-304.
  26. Claussen CF. Diagnostic and practical value of craniocorpography in vertiginous syndromes. Presse Med. 1986 Sep 25;15(31):1565-1568.
  27. Haguenauer JP, Cantenot F, et al. Treatment of equilibrium disorders with Ginkgo biloba extract: a multicenter double-blind drug vs. placebo study. Presse Med. 1986 Sep 25;15(31):1569-72.
  28. Issing W, Klein P, et al. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med. 2005 Feb;11(1):155-60.
  29. Baggio E, Gandini R, et al. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure: CoQ10 Drug Surveillance Investigators. Mol Aspects Med. 1994;(suppl 15):s287-s294.
  30. Lien HC, Sun WM, et al. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol. 2003 Mar;284(3):G481-G489.
  31. Grontved A, Hentzer E. Vertigo-reducing effect of ginger root: a controlled clinical study. ORL J Otorhinolaryngol Relat Spec. 1986;48(5):282-6.
  32. Grontved A, Brask T, et al. Ginger root against seasickness: a controlled trial on the open sea. Acta Otolaryngol. 1988 Jan-Feb;105(1-2):45-9.
  33. Holtmann S, Clarke AH, et al. The anti-motion sickness mechanism of ginger: a comparative study with placebo and dimenhydrinate. Acta Otolaryngol. 1989 Sep-Oct;108(3-4):168-74.